Lowery, C. D., Dowless, M., Renschler, M., Blosser, W., VanWye, A. B., Stephens, J. R., . . . Stancato, L. F. (2018). Broad spectrum activity of the checkpoint kinase 1 inhibitor prexasertib as a single agent or chemopotentiator across a range of preclinical pediatric tumor models. Clin Cancer Res.
Citação norma ChicagoLowery, Caitlin D., et al. "Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib As a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models." Clin Cancer Res 2018.
MLA CitationLowery, Caitlin D., et al. "Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib As a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models." Clin Cancer Res 2018.